Long-term treatment with relacorilant led to a sustained decrease in blood pressure, blood sugar levels, and body weight in people with Cushing’s syndrome, new data from an extension study shows. The extension study (NCT03604198) is assessing relacorilant’s long-term safety and efficacy in 116 people with Cushing’s who completed…
Read more
Korlym (mifepristone) significantly reduced levels of hemoglobin A1c, a marker that reflects blood sugar levels over the previous months, in people with Cushing’s syndrome and difficult-to-control type 2 diabetes. That’s according to new data from a Phase 4 clinical trial, CATALYST (NCT05772169), which screened 1,057 patients with difficult-to-control…
Another year has come and gone. 2024 was a big year for me. I went through several medication changes and increases in dosages, an egg-freezing cycle, started a new job, and made a few big life decisions. I worked on writing a novel and shared my story with all…
Becoming educated and informed about Cushing’s disease is a good first step. Here you’ll find general information such as the diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your Cushing’s journey.
Besides surgery, there are several therapeutic strategies that may be used to manage Cushing’s disease. Here you can find more information about some of the approved and experimental treatments.
Get regular updates to your inbox.
